SEC Filings
Monopar Says $129.4 Million Can Fund Its Drug Push Through At Least March 2028
The funding estimate includes a potential Wilson disease drug launch as Monopar works to finish its FDA application.
SEC Filings
The funding estimate includes a potential Wilson disease drug launch as Monopar works to finish its FDA application.
SEC Filings
California's conditions derailed the planned expansion; Intermex disputes Western Union's right to terminate the agreement.
SEC Filings
The CEO handoff is scheduled for January 15, 2027, alongside a permanent finance chief and revised board pay.
SEC Filings
The software company kept its outlook intact and named an Adobe finance executive to succeed its retiring CFO.
SEC Filings
Part of the money is intended to repay loans as the company seeks conditional relief from revenue requirements.
SEC Filings
The beverage and coffee company modeled leverage falling from approximately 4.1 times to 3.8 times after the offering and repayments.
SEC Filings
The new shares account for about 17% of the stated post-offering total, with initial liver-disease trial data expected in 2027.
SEC Filings
CorMedix suspended its 2027 DefenCath sales outlook while keeping its 2026 revenue forecast at $325 million to $345 million.
SEC Filings
The retirement-services subsidiary's update comes alongside Apollo's financing for a previously announced investment.
SEC Filings
The ODG purchase takes commercial work from about 20% to 28% of revenue and adds performance-based employee awards.
SEC Filings
Long-term follow-up showed five of eight patients maintained functional cure, while three lost that status but stayed partial cures.
SEC Filings
Sales reached $269.3 million, but the operating loss widened to $34.2 million as expenses grew.